Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
NASH
Sort By
Newest First
Sign in
1 / 1
1 / 1
Liver Disease
Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor
Robert Foster, Pharm.D., Ph.D.
Hepion Pharmaceuticals
PAO-06-022-CL-01
Jun 02, 2022
Clinical Trials
Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH
Lipocine Inc.
PR-M11-18-NI-022
Nov 07, 2018
